நினா பரத்வாஜ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நினா பரத்வாஜ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நினா பரத்வாஜ் Today - Breaking & Trending Today

Novel personalised cancer vaccine safe: Study | INDIA New England News


New York– A new personalised cancer vaccine, developed by the US researchers, is safe and beneficial for patients with different cancers, including lung and bladder, results of phase I clinical trials have shown.
“While immunotherapy has revolutionised the treatment of cancer, the vast majority of patients do not experience a significant clinical response with such treatments,” said Thomas Marron, Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, in New York, US.A
“Cancer vaccines, which typically combine tumour-specific targets that the immune system can learn to recognise and attack to prevent recurrence of cancer. The vaccine also contains an adjuvant that primes the immune system to maximise the efficacy,” Maron said. ....

United States , New York , Nina Bhardwaj , Thomas Marron , Immunotherapy Programme , American Association For Cancer Research , Icahn School Of Medicine At Mount Sinai , Tisch Cancer Institute At Mount Sinai , Assistant Professor , Medical Oncology , Icahn School , Mount Sinai , Tisch Cancer Institute , American Association , Cancer Research , Annual Meeting , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் , நினா பரத்வாஜ் , தாமஸ் மரோன் , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , டிஷ் புற்றுநோய் நிறுவனம் இல் ஏற்ற சினை , உதவியாளர் ப்ரொஃபெஸர் , மருத்துவ புற்றுநோயியல் , இக்ஹ்ன் பள்ளி ,

Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai


Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai
Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai
Immunicum AB (publ; IMMU.ST) announced today the initiation of a research collaboration with the laboratory of Nina Bhardwaj, M.D., Ph.D., Director of Immunotherapy and the Medical Director of the Vaccine and Cell Therapy Core Facility, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York City.
Dr. Bhardwaj is a leading researcher who has made significant contributions to the field of human dendritic cells and specifically their mode of action. Her translational research has resulted in the development of receptor agonist- and dendritic cell-based vaccines for the treatment of both cancer and infectious diseases, and she has pioneered neoantigen vaccine studies at The Tisch Cancer Institute. ....

New York , United States , Sijme Zeilemaker , Alex Karlsson Parra , Erik Manting , Eva Mulder , Nina Bhardwaj , Sophia Hergenhan , Initiates Research Collaboration , Icahn School Of Medicine At Mount Sinai , Tisch Cancer Institute , Trophic Communications , Press Release , Icahn School , Mount Sinai , Medical Director , Cell Therapy Core Facility , Tisch Cancer , Icahn Mount Sinai , Investor Relations , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஈவா முல்டர் , நினா பரத்வாஜ் , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , டிஷ் புற்றுநோய் நிறுவனம் ,